DUBAI — Neobiocon, a Dubai-based firm set up to manufacture bio-pharmaceutical products for life threatening diseases, will be spending Dh3 million over the next three years from "market creation" up to the time that the facility starts its operation.
A joint venture between Biocon, a leading Indian biotechnology firm based in Bangalore, and the Abu Dhabi-based pharmaceutical manufacturer, Neopharma, Neobiocon will be producing "affordable" medicines for cancer, diabetes, auto-immune disorders, cardiology and anti-obesity, among others.
Read More...
Please give information about the location,registeration,and job oppurtunites.
Please provide information about clinical research job opportunities.
Please give me information about clinical research jobs in Dubai
Please help me by providing the information about clinical research job opportunities in Dubai
please give me information about clinical research job in UAE
Please provide me information about clinical research opportunities in neobiocon&when it will start functioning in Dubiotech.
Please provide me information about clinical research opportunities in neobiocon &when it will start functioning in dubiotech.
Post a Comment